Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Breast Neoplasms × Remifentanil × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 4 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Prostatic Neoplasms 1 Postoperative Complications 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Ovarian Cysts 1 Myofibroma 1 Liver Neoplasms 1 Encephalocele 1 Cholecystitis 1 Breast Neoplasms 1

Interventions

Exercise 99 Surveys and Questionnaires 49 Magnetic Resonance Spectroscopy 45 Early Intervention, Educational 44 Acupuncture Therapy 41 Methods 38 Blood Specimen Collection 38 Standard of Care 37 Educational Status 37 Radiotherapy 35 Mammography 35 Control Groups 30 Therapeutics 27 Counseling 27 Psychiatric Rehabilitation 26 Sentinel Lymph Node Biopsy 23 Cyclophosphamide 23 Biopsy 22 Yoga 19 Resistance Training 18 Palliative Care 18 Cognitive Behavioral Therapy 17 Mastectomy, Segmental 16 High-Energy Shock Waves 16 Practice Guidelines as Topic 15 Magnetic Resonance Imaging 15 Tamoxifen 14 Neoadjuvant Therapy 14 Interviews as Topic 14 Doxorubicin 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04077827 2020-09-10

TIVA

National and Kapodistrian University of Athens

Phase NA Completed

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡